These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

380 related articles for article (PubMed ID: 23773767)

  • 1. Role of the mTOR signaling pathway in epilepsy.
    Meng XF; Yu JT; Song JH; Chi S; Tan L
    J Neurol Sci; 2013 Sep; 332(1-2):4-15. PubMed ID: 23773767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanistic target of rapamycin (mTOR) in tuberous sclerosis complex-associated epilepsy.
    Curatolo P
    Pediatr Neurol; 2015 Mar; 52(3):281-9. PubMed ID: 25591831
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mammalian target of rapamycin (mTOR) inhibition as a potential antiepileptogenic therapy: From tuberous sclerosis to common acquired epilepsies.
    Wong M
    Epilepsia; 2010 Jan; 51(1):27-36. PubMed ID: 19817806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic role of mammalian target of rapamycin (mTOR) inhibition in preventing epileptogenesis.
    McDaniel SS; Wong M
    Neurosci Lett; 2011 Jun; 497(3):231-9. PubMed ID: 21354266
    [TBL] [Abstract][Full Text] [Related]  

  • 5. mTOR inhibitors as a new therapeutic option for epilepsy.
    Curatolo P; Moavero R
    Expert Rev Neurother; 2013 Jun; 13(6):627-38. PubMed ID: 23739000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. mTOR inhibition modulates epileptogenesis, seizures and depressive behavior in a genetic rat model of absence epilepsy.
    Russo E; Citraro R; Donato G; Camastra C; Iuliano R; Cuzzocrea S; Constanti A; De Sarro G
    Neuropharmacology; 2013 Jun; 69():25-36. PubMed ID: 23092918
    [TBL] [Abstract][Full Text] [Related]  

  • 7. mTOR pathway inhibition as a new therapeutic strategy in epilepsy and epileptogenesis.
    Citraro R; Leo A; Constanti A; Russo E; De Sarro G
    Pharmacol Res; 2016 May; 107():333-343. PubMed ID: 27049136
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of mTOR inhibitors in epilepsy treatment.
    Sadowski K; Kotulska-Jóźwiak K; Jóźwiak S
    Pharmacol Rep; 2015 Jun; 67(3):636-46. PubMed ID: 25933981
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting the Mammalian Target of Rapamycin for Epileptic Encephalopathies and Malformations of Cortical Development.
    Jeong A; Wong M
    J Child Neurol; 2018 Jan; 33(1):55-63. PubMed ID: 29246093
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Focal malformations of cortical development: new vistas for molecular pathogenesis.
    Lim KC; Crino PB
    Neuroscience; 2013 Nov; 252():262-76. PubMed ID: 23892008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mammalian target of rapamycin (mTOR) pathways in neurological diseases.
    Wong M
    Biomed J; 2013; 36(2):40-50. PubMed ID: 23644232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TORC1-dependent epilepsy caused by acute biallelic Tsc1 deletion in adult mice.
    Abs E; Goorden SM; Schreiber J; Overwater IE; Hoogeveen-Westerveld M; Bruinsma CF; Aganović E; Borgesius NZ; Nellist M; Elgersma Y
    Ann Neurol; 2013 Oct; 74(4):569-79. PubMed ID: 23720219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mammalian target of rapamycin (mTOR) inhibition: potential for antiseizure, antiepileptogenic, and epileptostatic therapy.
    Ryther RC; Wong M
    Curr Neurol Neurosci Rep; 2012 Aug; 12(4):410-8. PubMed ID: 22544534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Finding a better drug for epilepsy: the mTOR pathway as an antiepileptogenic target.
    Galanopoulou AS; Gorter JA; Cepeda C
    Epilepsia; 2012 Jul; 53(7):1119-30. PubMed ID: 22578218
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of mTOR signaling pathway is secondary to neuronal excitability in a mouse model of mesio-temporal lobe epilepsy.
    Shima A; Nitta N; Suzuki F; Laharie AM; Nozaki K; Depaulis A
    Eur J Neurosci; 2015 Apr; 41(7):976-88. PubMed ID: 25605420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of mammalian target of rapamycin reduces epileptogenesis and blood-brain barrier leakage but not microglia activation.
    van Vliet EA; Forte G; Holtman L; den Burger JC; Sinjewel A; de Vries HE; Aronica E; Gorter JA
    Epilepsia; 2012 Jul; 53(7):1254-63. PubMed ID: 22612226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. mTOR signaling in epilepsy: insights from malformations of cortical development.
    Crino PB
    Cold Spring Harb Perspect Med; 2015 Apr; 5(4):. PubMed ID: 25833943
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Autism, epilepsy and tuberous sclerosis complex: a functional model linked to mTOR pathway].
    García-Peñas JJ; Carreras-Sááez I
    Rev Neurol; 2013 Feb; 56 Suppl 1():S153-61. PubMed ID: 23446718
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of cell death and epileptogenesis by the mammalian target of rapamycin (mTOR): a double-edged sword?
    Zeng LH; McDaniel S; Rensing NR; Wong M
    Cell Cycle; 2010 Jun; 9(12):2281-5. PubMed ID: 20603607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Developing Antiepileptogenic Drugs for Acquired Epilepsy: Targeting the Mammalian Target of Rapamycin (mTOR) Pathway.
    Zeng LH; Rensing NR; Wong M
    Mol Cell Pharmacol; 2009 Jan; 1(3):124-129. PubMed ID: 20419051
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.